Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free AVNS Stock Alerts

Avanos Medical (AVNS) Short Interest Ratio & Short Volume

Avanos Medical logo
$24.72 +0.02 (+0.06%)
Closing price 03:59 PM Eastern
Extended Trading
$24.75 +0.03 (+0.11%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Avanos Medical Short Interest Overview

As of April 30, 2026, Avanos Medical (AVNS) had a short interest of 1.21 million shares sold short, representing 2.65% of the public float. This marks a -39.59% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.8, meaning it would take 0.8 days of the average trading volume of 1.24 million shares to cover all short positions.

Current Short Interest
1,211,005 shares
Previous Short Interest
2,004,529 shares
Change Vs. Previous Month
-39.59%
Dollar Volume Sold Short
$29.85 million
Short Interest Ratio
0.8 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
46,830,000 shares
Short Percent of Float
2.65%
Today's Trading Volume
849,559 shares
Average Trading Volume
1,242,821 shares
Today's Volume Vs. Average
68%
Short Selling Avanos Medical?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Avanos Medical and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AVNS Short Interest Over Time

AVNS Days to Cover Over Time

AVNS Percentage of Float Shorted Over Time

Avanos Medical Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20261,211,005 shares $29.85 million -39.6%2.6%0.75 $24.65
4/15/20262,004,529 shares $49.37 million -7.6%4.4%0.63 $24.63
3/31/20262,168,244 shares $30.38 million -7.1%4.8%4.12 $14.01
3/13/20262,334,691 shares $32.00 million -10.5%5.1%3.6 $13.71
2/27/20262,607,300 shares $36.81 million -11.8%5.8%3.83 $14.12
2/13/20262,954,825 shares $44.04 million -13.3%6.5%5.04 $14.91
1/30/20263,409,612 shares $45.42 million +5.9%7.5%5.8 $13.32
1/15/20263,218,424 shares $39.81 million +23.1%7.1%5.39 $12.37
12/31/20252,613,713 shares $29.35 million -5.2%5.8%4.9 $11.23
12/15/20252,757,599 shares $32.75 million -1.4%6.1%5.27 $11.88
11/28/20252,796,444 shares $32.83 million +8.2%6.2%5.08 $11.74
11/14/20252,585,208 shares $29.45 million +8.7%5.7%4.56 $11.39
10/31/20252,378,661 shares $26.39 million +2.5%5.3%5.67 $11.10
10/15/20252,320,000 shares $26.32 million -9.7%5.2%3.7 $11.35
9/30/20252,570,000 shares $29.73 million -19.4%5.7%4 $11.57
9/15/20253,190,000 shares $39.17 million +16.9%7.1%5.2 $12.28
8/31/20252,730,000 shares $32.58 million +14.2%6.1%4.7 $11.93
8/15/20252,390,000 shares $26.72 million +25.8%5.3%4.3 $11.18
7/31/20251,900,000 shares $21.20 million +25.8%4.2%3.9 $11.16
7/15/20251,510,000 shares $17.41 million +3.4%3.4%3.2 $11.53
6/30/20251,460,000 shares $17.89 million -12.6%3.3%3.1 $12.25
6/15/20251,670,000 shares $20.22 million +7.1%3.7%3.5 $12.11
5/31/20251,560,000 shares $19.62 million +18.2%3.5%3.1 $12.58
5/15/20251,320,000 shares $16.83 million +16.8%3.0%2.5 $12.75
4/30/20251,130,000 shares $14.17 million +21.0%2.5%2.2 $12.54
4/15/2025934,200 shares $11.25 million +29.1%2.1%1.8 $12.05
3/31/2025723,500 shares $10.37 million -9.2%1.6%1.3 $14.34
3/15/2025796,500 shares $11.51 million -10.4%1.8%1.5 $14.45
2/28/2025888,700 shares $13.39 million +25.7%2.0%1.8 $15.07
2/15/2025707,000 shares $11.70 million +11.9%1.6%1.5 $16.55
1/31/2025632,000 shares $10.90 million -5.2%1.4%1.4 $17.25
1/15/2025666,900 shares $10.53 million -2.1%1.5%1.6 $15.79
12/31/2024681,400 shares $10.85 million -6.4%1.5%2 $15.92
12/15/2024727,700 shares $13.08 million +18.4%1.6%2.6 $17.97
11/30/2024614,500 shares $11.77 million +11.3%1.4%2.4 $19.16
11/15/2024552,300 shares $10.32 million -9.0%1.2%2.2 $18.69
10/31/2024607,200 shares $11.34 million -19.6%1.4%2.7 $18.68
10/15/2024754,800 shares $17.21 million -0.9%1.7%3.6 $22.80
9/30/2024761,800 shares $18.30 million -7.0%1.7%3.4 $24.03
9/15/2024819,500 shares $19.67 million -1.2%1.8%3.5 $24.00
The one number Musk can't hide in the S-1 (Ad)

When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requires more electricity than some small countries use in a year, and SEC rules require it be disclosed. When that figure goes public, every analyst on Wall Street will race to identify the supplier. One small company already has a $1.5 billion backlog - and Dylan Jovine has the name and ticker.tc pixel

See the stock the SpaceX S-1 filing is likely to expose
8/31/2024829,800 shares $20.10 million +13.5%1.9%3.8 $24.22
8/15/2024730,900 shares $16.87 million +5.4%1.6%3.5 $23.08
7/31/2024693,200 shares $16.54 million -7.8%1.5%3.3 $23.86
7/15/2024751,600 shares $15.71 million -11.0%1.7%3.6 $20.90
6/30/2024844,800 shares $16.83 million -26.5%1.9%4.2 $19.92
6/15/20241,150,000 shares $22.13 million +9.5%2.6%5.7 $19.24
5/31/20241,050,000 shares $20.88 million -3.7%2.3%5.2 $19.89
5/15/20241,090,000 shares $21.83 million +12.6%2.4%5.2 $20.03
4/30/2024968,300 shares $17.51 million -17.2%2.2%4 $18.08
4/15/20241,170,000 shares $22.05 million -0.9%2.6%4.7 $18.85
3/31/20241,180,000 shares $23.49 million -11.9%2.6%4.1 $19.91
3/15/20241,340,000 shares $25.59 million +6.4%3.0%4.5 $19.10
2/29/20241,260,000 shares $23.40 million +1.6%2.8%3.8 $18.57
2/15/20241,240,000 shares $24.42 million +4.2%2.7%3.8 $19.69
1/31/20241,190,000 shares $22.82 million +23.3%2.6%3.8 $19.18
1/15/2024964,800 shares $18.81 million +1.7%2.1%3.1 $19.50
12/31/2023948,600 shares $21.28 million -13.8%2.1%3.1 $22.43
12/15/20231,100,000 shares $23.91 million +10.6%2.4%3.8 $21.74
11/30/2023994,600 shares $21.44 million -5.3%2.2%3.5 $21.56
11/15/20231,050,000 shares $22.51 million +14.8%2.3%3.3 $21.44
10/31/2023914,600 shares $16.78 million -0.2%2.0%2.7 $18.35
10/15/2023916,000 shares $16.90 million -9.3%2.0%2.9 $18.45
9/30/20231,010,000 shares $20.42 million +18.0%2.2%3.3 $20.22
9/15/2023855,800 shares $17.06 million -1.7%1.9%2.9 $19.93
8/31/2023870,200 shares $18.30 million +8.0%1.9%2.9 $21.03
8/15/2023805,800 shares $17.97 million +6.8%1.8%3.2 $22.30
7/31/2023754,800 shares $18.46 million -5.2%1.7%3 $24.46
7/15/2023796,000 shares $20.05 million -4.3%1.8%3 $25.19
6/30/2023832,100 shares $21.26 million -0.4%1.9%3.3 $25.55
6/15/2023835,500 shares $21.61 million -9.2%1.8%3.1 $25.86
5/31/2023919,900 shares $22.53 million +4.6%2.1%3.4 $24.49
5/15/2023879,700 shares $20.40 million +1.4%1.9%3.3 $23.19
4/30/2023867,900 shares $25.64 million +0.3%1.9%3.3 $29.54
4/15/2023865,700 shares $25.81 million -7.4%1.9%3.6 $29.81
3/31/2023935,300 shares $27.82 million -22.1%2.1%3.8 $29.74
3/15/20231,200,000 shares $33.44 million +13.2%2.6%4.9 $27.87
2/28/20231,060,000 shares $29.75 million +5.0%2.3%4.8 $28.07
2/15/20231,010,000 shares $30.49 million +10.9%2.2%4.8 $30.19
1/31/2023910,700 shares $27.90 million +2.0%2.0%4.1 $30.64
1/15/2023892,900 shares $26.25 million +3.4%2.0%4 $29.40
12/30/2022863,600 shares $23.37 million +19.2%1.9%3.9 $27.06
12/15/2022724,600 shares $19.05 million -5.1%1.6%3.3 $26.29
11/30/2022763,600 shares $20.54 million -15.1%1.7%3.2 $26.90
11/15/2022899,500 shares $23.81 million -16.7%2.0%3.7 $26.47
10/31/20221,080,000 shares $23.92 million -12.2%2.4%4.3 $22.15
10/15/20221,230,000 shares $24.58 million +2.5%2.7%4.9 $19.98
9/30/20221,200,000 shares $26.14 million -3.2%2.6%4.7 $21.78
9/15/20221,240,000 shares $29.08 million -3.1%2.7%4.8 $23.45
8/31/20221,280,000 shares $31.53 million +5.8%2.8%5.3 $24.63
8/15/20221,210,000 shares $35.80 million +6.1%2.7%5 $29.59
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
7/31/20221,140,000 shares $32.34 million -0.9%2.5%4.5 $28.37
7/15/20221,150,000 shares $30.88 million +5.5%2.5%4.4 $26.85
6/30/20221,090,000 shares $29.80 million -9.9%2.4%4 $27.34
6/15/20221,210,000 shares $31.02 million -6.2%2.6%4.3 $25.64
5/31/20221,290,000 shares $37.01 million -5.2%2.8%4.2 $28.69
5/15/20221,360,000 shares $35.86 million +7.9%2.9%4 $26.37
4/30/20221,260,000 shares $36.74 million +4.1%2.7%3.7 $29.16
4/15/20221,210,000 shares $38.64 million -4.7%2.6%3.5 $31.93
3/31/20221,270,000 shares $42.55 million -5.2%2.7%3.5 $33.50
3/15/20221,340,000 shares $42.55 million +5.5%2.9%3.7 $31.75
2/28/20221,270,000 shares $44.95 million -5.9%2.7%3 $35.39
2/15/20221,350,000 shares $41.73 million +4.7%2.8%3.3 $30.91
1/31/20221,290,000 shares $39.04 million +7.5%2.7%3.3 $30.26
1/15/20221,200,000 shares $39.20 million +8.1%2.5%3.1 $32.67
12/31/20211,110,000 shares $38.48 million -10.5%2.3%3 $34.67
12/15/20211,240,000 shares $37.77 million -6.8%2.6%3.5 $30.46
11/30/20211,330,000 shares $40.13 million +3.1%2.8%4.3 $30.17
11/15/20211,290,000 shares $43.31 million +12.2%2.7%4 $33.57
10/29/20211,150,000 shares $36.27 million -0.9%2.4%3.4 $31.54
10/15/20211,160,000 shares $38.09 million -6.5%2.4%3.2 $32.84
9/30/20211,240,000 shares $38.69 million +4.2%2.6%3.5 $31.20
9/15/20211,190,000 shares $37.82 million +13.3%2.5%3.3 $31.78
8/31/20211,050,000 shares $34.65 million -3.7%2.2%3.1 $33.00
8/13/20211,090,000 shares $37.32 million -6.8%2.3%3.6 $34.24
7/30/20211,170,000 shares $44.39 million -8.6%2.5%2.4 $37.94
7/15/20211,280,000 shares $44.10 million +23.1%2.7%2.8 $34.45
6/30/20211,040,000 shares $37.82 million -2.8%2.2%2.2 $36.37
6/15/20211,070,000 shares $42.77 million -12.3%2.3%2.3 $39.97
5/28/20211,220,000 shares $48.92 million +25.3%2.6%2.7 $40.10

AVNS Short Interest - Frequently Asked Questions

Short interest is the volume of Avanos Medical shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,211,005 shares of AVNS short. 2.65% of Avanos Medical's shares are currently sold short. Learn More on Avanos Medical's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVNS shares currently have a short interest ratio of 0.8. Learn More on Avanos Medical's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.65% of Avanos Medical's floating shares are currently sold short.

Avanos Medical saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 1,211,005 shares, a drop of 39.6% from the previous total of 2,004,529 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.65% of Avanos Medical's shares are currently sold short. Here is how the short interest of companies compare to Avanos Medical: Snail, Inc. (12.73%), Liquidia Corporation (15.04%), Envista Holdings Corporation (5.86%), iRhythm Technologies (8.77%), LivaNova PLC (6.18%), Warby Parker Inc. (11.96%), MiniMed Group Inc (1.30%), Soleno Therapeutics, Inc. (13.38%), LeMaitre Vascular, Inc. (5.49%), TransMedics Group, Inc. (25.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling AVNS is an investing strategy that aims to generate trading profit from Avanos Medical as its price is falling. AVNS shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Avanos Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVNS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVNS, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AVNS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:AVNS) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
The cat is out the bag
Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...
Porter & Company | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
They're not telling you how bad this could get
Valuations are stretched to levels seen only a handful of times in the last hundred years — yet most retiremen...
Parkview Capital Group | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel